Quest Diagnostics Inc DGX

NYSE US Health Care

$233.01 ▼ -0.55% ($-1.29)

Index member: S&P 500

Open $234.00

Prev Close $234.30

Day Range $232.01 – $235.29

52W Range $166.76 – $240.13

Market Cap $25.72B

P/E (TTM) 24.38

Beta 0.55

Div Yield 1.47%

EPS (TTM) $9.44

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NEW YORK STOCK EXCHANGE, INC.
Currency	USD
IPO Date	1996-12-17
Shares Out.	110,370,000
Website	questdiagnostics.com/ ↗
Phone	13026587581
Employees	57,000
Revenue	$3.04B
Gross Profit	$1.03B
Net Income	$334.0M
Free Cash Flow	$1.35B
Total Assets	$16.94B
Total Liabilities	$9.04B
Equity	$7.82B

About Quest Diagnostics Inc

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Quest Diagnostics Inc is a publicly traded company under the ticker symbol DGX on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.